Tower Research Capital (TRC)’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-877
| Closed | -$7.6K | – | 6091 |
|
|
2024
Q2 | $7.6K | Sell |
877
-50
| -5% | -$433 | ﹤0.01% | 4447 |
|
|
2024
Q1 | $8.11K | Sell |
927
-61
| -6% | -$534 | ﹤0.01% | 4078 |
|
|
2023
Q4 | $7.36K | Buy |
988
+208
| +27% | +$1.55K | ﹤0.01% | 4621 |
|
|
2023
Q3 | $4.5K | Buy |
780
+762
| +4,233% | +$4.4K | ﹤0.01% | 4857 |
|
|
2023
Q2 | $131 | Sell |
18
-17
| -49% | -$124 | ﹤0.01% | 5761 |
|
|
2023
Q1 | $0 | Buy |
+35
| New | – | ﹤0.01% | 6442 |
|
|
2022
Q4 | – | Sell |
-280
| Closed | -$3K | – | 6530 |
|
|
2022
Q3 | $3K | Buy |
+280
| New | +$3K | ﹤0.01% | 5448 |
|
|
2022
Q2 | – | Sell |
-1,051
| Closed | -$22K | – | 6663 |
|
|
2022
Q1 | $22K | Buy |
1,051
+678
| +182% | +$14.2K | ﹤0.01% | 3460 |
|
|
2021
Q4 | $22K | Sell |
373
-525
| -58% | -$31K | ﹤0.01% | 3581 |
|
|
2021
Q3 | $85K | Buy |
898
+820
| +1,051% | +$77.6K | ﹤0.01% | 2532 |
|
|
2021
Q2 | $13K | Sell |
78
-554
| -88% | -$92.3K | ﹤0.01% | 4249 |
|
|
2021
Q1 | $122K | Buy |
+632
| New | +$122K | ﹤0.01% | 2439 |
|